Amneal Pharmaceuticals, Inc. (AMRX) › Weighted Average Diluted SharesAmneal Pharmaceuticals, Inc. (AMRX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2018-12-31: 127.25M2019-12-31: 132.11M2020-12-31: 148.91M2021-12-31: 151.82M2022-12-31: 150.94M2023-12-31: 176.14M2024-12-31: 308.98M2025-12-31: 324.81M324.81M2018-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31324.81M+5.1%2026-02-27From 2025-01-012024-12-31308.98M+75.4%2026-02-27From 2024-01-012023-12-31176.14M+16.7%2026-02-27From 2023-01-012022-12-31150.94M-0.6%2025-02-28From 2022-01-012021-12-31151.82M+2.0%2024-03-14From 2021-01-012020-12-31148.91M+12.7%2023-03-03From 2020-01-012019-12-31132.11M+3.8%2022-03-01From 2019-01-012018-12-31127.25M—2021-03-01From 2018-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)